EA
CMD

Emerald Acquisition’s Cantel Medical Corporation CMD Stock Holding History

Emerald Acquisition’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.62M Sell
20,758
-35,395
-63% -$2.57M ﹤0.01% 1863
2016
Q2 		$3.86M Buy
+56,153
New +$3.87M 0.01% 1488

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Emerald Acquisition's CMD Position: Q3 2016 in Review

Emerald Acquisition reduced its Cantel Medical Corporation (CMD) stake by 63% in Q3 2016, selling an estimated $2.57M and leaving 20,758 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

Emerald Acquisition first reported a position in CMD in Q2 2016 and has held it in 2 quarters since. The position peaked at $3.86M in Q2 2016. 227 funds tracked by Wall St. Rank hold CMD as of Q3 2016.

  • Emerald Acquisition held 20,758 shares of Cantel Medical Corporation worth $1.62M as of Q3 2016.
  • Emerald Acquisition sold 35,395 Cantel Medical Corporation shares in Q3 2016, an estimated $2.57M.
  • Cantel Medical Corporation made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1863 holding.
  • Emerald Acquisition first reported a position in Cantel Medical Corporation in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Cantel Medical Corporation position peaked at $3.86M in Q2 2016.
  • 227 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.